China News Service, Beijing, April 30 (Reporter Ma Haiyan) The "Caring Rieter Patient Assistance Project" initiated by the China Primary Health Care Foundation started on the same day. The project will include patients with acute coronary syndrome that meet the corresponding medical conditions as the target of the project.
According to statistics, the number of patients with cardiovascular disease in China is as high as 290 million. Increased low-density lipoprotein cholesterol has been identified as one of the important causes of cardiovascular disease. Especially for those very high-risk patients who have suffered from cardiovascular disease within 1 year, if they fail to intervene effectively, it may cause relapse and threaten health and life.
Professor Qian Juying, Zhongshan Hospital Affiliated to Fudan University, said that acute coronary syndrome (ACS) is the main cause of death in patients with cardiovascular disease. ACS is critically ill and has a high mortality rate. After the onset of the disease, long-term treatment is required. The patient, family and society Bring a heavy burden.
The "Caring Rieter Patient Assistance Project" aims to help patients with ACS obtain the treatment of the innovative PCSK9 inhibitor Polida (Alixiu monoclonal antibody injection), help patients improve their quality of life, and at the same time reduce the treatment of patients and their families. Economic burden, improve the accessibility of medicines.
Wang Lin, Executive Secretary of the China Occupational Health Care Foundation Life Oasis Patient Welfare Fund, said that for a long time, the foundation has always made it its mission to provide fair, accessible and systematic health services and achieve a higher level of universal health. It is believed that the care of Rieter ’s assistance program will benefit more patients, enable them to receive standardized treatment, improve the availability of treatment drugs, and reduce the economic burden of disease on patients ’families and society.
It is reported that the online application channels of the project's official website and public account have been opened simultaneously, and patients in need can apply through relevant channels. (Finish)